More News
14 November 2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies14 November 2019
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases14 November 2019
Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York14 November 2019
Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day14 November 2019
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders13 November 2019
Avidity Biosciences Completes $100 Million Series C Financing13 November 2019
COI Pharmaceuticals Announces Acquisition of Calporta by Merck11 November 2019
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers9 November 2019
Ningbo Tai Kang Medical Technology Co., Ltd Announces Global Licensing Agreement With AstraZeneca7 November 2019
Novo Nordisk obtains exclusive worldwide licence to potential NASH candidate UD-014 from UBE Industries7 November 2019
Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD03647 November 2019
Alvotech and STADA Agree on Strategic Biosimilar Partnership6 November 2019
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor6 November 2019
Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate5 November 2019
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China5 November 2019
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks1 November 2019
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China31 October 2019
Pandion and Astellas Announce Collaboration to Deliver Pancreas-Targeted Immunomodulators30 October 2019
LEO Pharma enters into option agreement with Ubiquigent for access to novel compoundsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports